Risk factors
ABVC Biopharma (ABVC) risk factors
Item 1A of every ABVC Biopharma, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors51 risks3 new1 dropped4 reworded
Insider ownership concentration dropped from 61.4% to 19% in the reworded risks.
Filed Mar 03, 2026 - FY2024 10-K risk factors49 risks
Clinical-stage biopharmaceutical company dependent on external financing and licensing partners for drug and medical device development.
Filed Apr 15, 2025